ctrl K

Watchlist Price Alert

Orchestra BioMed Inc. (OBIO)

NASDAQ: OBIO · Real-Time Price · USD

2.81

-0.17 (-5.70%)

At close: Jun 27, 2025, 3:59 PM

2.78

-0.89%

After-hours: Jun 27, 2025, 04:32 PM EDT

Orchestra BioMed Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2.64M	2.76M	3.53M	-782K	5.7M
Cost of Revenue	204K	186K	322K	199K	145K
Gross Profit	2.43M	2.57M	3.21M	-981K	5.56M
Operating Income	-64.3M	-51.51M	-32.66M	-21.8M	-18.75M
Interest Income	3.36M	3.85M	50K	927K	331K
Pretax Income	-61.02M	-49.12M	-33.61M	-23.01M	-21.36M
Net Income	-61.02M	-49.12M	-33.61M	-23.01M	-21.36M
Selling & General & Admin	23.93M	20.26M	13.92M	7.93M	10.83M
Research & Development	42.8M	33.82M	21.95M	12.89M	13.48M
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	66.73M	54.08M	35.87M	20.82M	24.31M
Interest Expense	n/a	n/a	n/a	927K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	66.94M	54.27M	36.19M	21.02M	24.45M
Income Tax Expense	n/a	n/a	-222K	927K	2.6M
Shares Outstanding (Basic)	36.82M	33.23M	14.99M	20.45M	20.45M
Shares Outstanding (Diluted)	36.82M	33.23M	14.99M	20.45M	20.45M
EPS (Basic)	-1.66	-1.48	-2.24	-1.13	-1.04
EPS (Diluted)	-1.66	-1.48	-2.24	-1.13	-1.04
EBITDA	-64.3M	-51.22M	-32.44M	-21.62M	-18.61M
EBIT	-64.3M	-51.51M	-32.66M	-21.8M	-18.75M
Depreciation & Amortization	n/a	287K	222K	181K	137K